![](https://viestories.com/wp-content/uploads/2024/07/Nurture-Well-Secures-Rs-50-Cr-Funding-Round-from-India-Inflection-Opportunity-Fund.webp)
Multi-category cookie maker Nurture Well, situated in Noida, announced the completion of the private placement round. The India Inflection Opportunity Fund (IIOF) has committed to investing Rs 50 crore in the business.
IIOF makes growth-stage investments in profitable firms backed by assets. IIOF has completed six mid-market investment transactions in the previous six months.
Premium cookies and biscuits in multiple categories are produced and sold by Nurture Well.
Read also – SkinInspired Secures $1.5 Mn Seed Funding Round Led by Unilever Ventures
According to Nurture Well, it has more than 150 business partners in its distribution network, which spans North Indian states like Uttar Pradesh, Himachal Pradesh, Punjab, Rajasthan, Uttarakhand, Delhi-NCR, and Jammu & Kashmir.
Madhu Lunawat, CIO of India Inflection Opportunity Fund, said: “We are thrilled with our investment in Nurture Well, a standout in the multi-category biscuit segment. FMCG industry holds immense potential and we are confident that Nurture Well’s dedication to quality and innovation positions it perfectly to capitalise on this growth,”
Saurabh Goel, Director of Nurture Well, said: “Our vision is to be a leading and innovative biscuit manufacturing company, recognised globally for our exceptional quality, diverse product range, and commitment to customer satisfaction,”
About Nurture Well
Founded in 2023 by Sanidhya Garg, NurtureWell is a premier biscuit manufacturing unit dedicated to excellence.
Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:
Startup Success Stories: Discover inspiring tales of startups overcoming challenges and achieving success.
Funding Startup News: Stay updated with the latest news and trends in startup funding and investment.
Startup Insights: Dive into in-depth analyses of various industries and market trends to make informed business decisions.